article thumbnail

Pfizer, looking for a jumpstart, leans into cancer drug research

BioPharma Drive: Drug Pricing

Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.

article thumbnail

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

Vial

In this article, we will define preclinical and clinical CROs, as well as highlight the unique needs and challenges of these organizations in their respective stages of drug research. billion by 2030 at a compound annual growth rate (CAGR) of 7.5% between 2024 and 2030. between 2024 and 2030. over this period.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Possible adulticidal drugs for Onchocerca volvulus

Drug Target Review

If these genomes that codes for the proposed enzymes and biomolecules are critical to the worms as projected by Cotton et al (2016), then thus it creates countless opportunity for adulticidal drugs to be developed. She spent one year as a research assistant, focusing on NTDs and one year as a teaching assistant, focusing on Pharmacology.

Drugs 105
article thumbnail

World Malaria Day 2021

The Pharma Data

Further, the EDCTP granted EUR 10 million over five years to the West African Network for Clinical Trials of Antimalarial Drugs , a collaboration between antimalarial drug researchers in Africa and Europe from 10 academic institutions, Novartis and MMV. The EDCTP grant of EUR 21.9 Video of No one should die of malaria.